The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-14.